What is the generic name?

LOPINAVIR AND RITONAVIR

What is the Trade Name for LOPINAVIR AND RITONAVIR?

Kaletra

What are the Indications for LOPINAVIR AND RITONAVIR?

• 1 INDICATIONS AND USAGE KALETRA is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients 14 days and older. Limitations of Use: Genotypic or phenotypic testing and/or treatment history should guide the use of KALETRA. The number of baseline lopinavir resistance-associated substitutions affects the virologic response to KALETRA [see Microbiology ( 12.4 )] . KALETRA is an HIV-1 protease inhibitor indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients (14 days and older). ( 1 )

References: https://open.fda.gov/